Oncolytics Biotech, Inc. Common Shares (ONCY) is a publicly traded Healthcare sector company. As of May 21, 2026, ONCY trades at $0.84 with a market cap of $92.91M and a P/E ratio of -2.77. ONCY moved +6.72% today. Year to date, ONCY is -15.03%; over the trailing twelve months it is +90.83%. Its 52-week range spans $0.33 to $1.53. Analyst consensus is strong buy with an average price target of $6.00. Rallies surfaces ONCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Oncolytics Biotech, Inc. Common Shares (ONCY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ONCY moved +6.72% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $0.84 |
| Market Cap | $92.91M |
| P/E Ratio | -2.77 |
| EPS | $-0.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.53 |
| 52-Week Low | $0.33 |
| Volume | 145 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-28.76M |
| Gross Margin | 0.00% |
4 analysts cover ONCY: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.00.